Moreover, it was shown that inhibited miR-34a led to the down-regulation of NF-κB, promoting the expression of HMGB1 and potentially contributing to portal vein tumor thrombus and cancer metastasis [227]. The gene discussed is HMGB1; the disease is cancer.